Clinical Trial Update: Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA) [Phase 1]

View source ↗

Summary

This document describes a Phase 1 clinical trial of Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) with Daratumumab for multiple myeloma. The current status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Daratumumab (daratumumab)

Snippet

Sponsor: National University of Ireland, Galway, Ireland | Conditions: Multiple Myeloma | Phase 1 | Status: UNKNOWN